Pharmacokinetic basis of the antiplatelet action of prasugrel
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.2011.00986.x/fullpdf
Reference54 articles.
1. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention;Hochholzer;Circulation,2005
2. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial;von Beckerath;Circulation,2005
3. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction;Matetzky;Circulation,2004
4. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?;Bliden;J. Am. Coll. Cardiol.,2007
5. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance;Siller-Matula;Thromb. Haemost.,2007
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The use of CytoSorb® in a prasugrel‐loaded patient undergoing emergent coronary artery bypass graft surgery;Clinical Case Reports;2023-03
2. The role and pharmacological properties of P2Y12 receptor in cancer and cancer pain;Biomedicine & Pharmacotherapy;2023-01
3. Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment;Journal of Cardiovascular Development and Disease;2022-11-16
4. Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of Prasugrel in Healthy Male Volunteers;Clinical Pharmacology in Drug Development;2022-10-17
5. Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis;Cells;2022-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3